logo
Select company
Select metric
$ -115.29MConsolidated Income
VS
Market
11
Sector
20
Industry
26
History
71
$ 3.04Close
$ 0.9 - $ 6.06 52-Week Range
Ticker Information

Ticker

ALEC

Company Name

ALECTOR INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ALECTOR INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ALEC - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -115.29M
3/31/2025$ -123.44M
12/31/2024$ -119.05M
9/30/2024$ -158.41M
6/30/2024$ -160.66M
3/31/2024$ -120.61M
12/31/2023$ -130.39M
9/30/2023$ -141.38M
6/30/2023$ -143.06M
3/31/2023$ -134.55M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ALECTOR INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -168.58M.
  • Over the past 5 years, ALECTOR INC's average Cons. Inc. has been $ -122.59M.
  • The median Cons. Inc. for ALECTOR INC during this period was $ -133.93M
  • ALECTOR INC reached its highest Cons. Inc. over the past 5 years at $ 36.26M.
  • The lowest Cons. Inc. recorded by ALECTOR INC in the same timeframe $ -212.2M

ALECTOR INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
SGMO : SANGAMO THERAPEUTICS INC $ -63.31MBDTX : BLACK DIAMOND THERAPEUTICS INC $ 14.44MTHTX : THERATECHNOLOGIES INC $ -6.68MENTA : ENANTA PHARMACEUTICALS INC $ -92.01MAGEN : AGENUS INC $ -170.4MPLX : PROTALIX BIOTHERAPEUTICS INC $ 6.28MSPRO : SPERO THERAPEUTICS INC $ -53.6MCSBR : CHAMPIONS ONCOLOGY INC $ 2.92MTRDA : ENTRADA THERAPEUTICS INC $ -73.35MCELU : CELULARITY INC $ -73.67M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

ALEC - Consolidated Income, Last 5 years

$ -212.2M

Minimum

Jun 30, 2021

$ 36.26M

Maximum

Jun 30, 2022

$ -122.59M

Average

$ -133.93M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M